louisiana semaglutide lawyer Wegovy Lawsuit louisiana semaglutide gastric intestinal obstruction

While recent findings suggesting potential efficacy of Eli Lilly's retatrutide in addressing NASH and NAFLD, patient options for treatment will continue to be limited absent FDA approval

Its important to anchor the conversation around GLP-1s on the fact that theyre indicated for something specific: Managing weight concerns, like obesity, associated with metabolic dysfunction and chronic diseasenot the normal, gradual weight gain associated with aging (and yes, sometimes menopause)

No datasets were generated or analyzed during this study

Additionally, the FDA was evaluating reports of hair loss and suicidal thoughts in patients taking Ozempic, Mounjaro, or Wegovy